171 related articles for article (PubMed ID: 35523718)
1. Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Ashy N; Alharbi L; Alkhamisi R; Alradadi R; Eljaaly K
J Infect Chemother; 2022 Aug; 28(8):1148-1152. PubMed ID: 35523718
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia.
Eljaaly K; Botaish A; Bahobail F; Almehmadi M; Assabban Z; Thabit AK; Alraddadi B; Aljabri A; Alqahtani N; Aseeri MA; Hashim A; Torres A
J Chemother; 2020 Feb; 32(1):1-6. PubMed ID: 31650904
[TBL] [Abstract][Full Text] [Related]
3. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
[TBL] [Abstract][Full Text] [Related]
4. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S
Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997
[TBL] [Abstract][Full Text] [Related]
5. Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
Cluver C; Novikova N; Eriksson DO; Bengtsson K; Lingman GK
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010485. PubMed ID: 28937705
[TBL] [Abstract][Full Text] [Related]
6. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.
Corrêa JC; Badaró R; Bumroongkit C; Mera JR; Dolmann AL; Juárez Martínez LG; Mayrinck LR; Tamez R; Yang JY
Clin Ther; 2003 May; 25(5):1453-68. PubMed ID: 12867221
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics for community-acquired pneumonia in adult outpatients.
Pakhale S; Mulpuru S; Verheij TJ; Kochen MM; Rohde GG; Bjerre LM
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD002109. PubMed ID: 25300166
[TBL] [Abstract][Full Text] [Related]
8. Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials.
Li XM; Wang FC; Yang F; Jin YH
Chin Med J (Engl); 2013; 126(11):2179-85. PubMed ID: 23769580
[TBL] [Abstract][Full Text] [Related]
9. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
Principi N; Esposito S
Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
[TBL] [Abstract][Full Text] [Related]
10. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
[TBL] [Abstract][Full Text] [Related]
11. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
Drehobl MA; De Salvo MC; Lewis DE; Breen JD
Chest; 2005 Oct; 128(4):2230-7. PubMed ID: 16236879
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review.
Al-Salloum J; Gillani SW; Mahmood RK; Gulam SM
J Int Med Res; 2021 Oct; 49(10):3000605211049943. PubMed ID: 34719987
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
Paladino JA; Gudgel LD; Forrest A; Niederman MS
Chest; 2002 Oct; 122(4):1271-9. PubMed ID: 12377852
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.
Plouffe J; Schwartz DB; Kolokathis A; Sherman BW; Arnow PM; Gezon JA; Suh B; Anzuetto A; Greenberg RN; Niederman M; Paladino JA; Ramirez JA; Inverso J; Knirsch CA
Antimicrob Agents Chemother; 2000 Jul; 44(7):1796-802. PubMed ID: 10858333
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review.
Cai Y; Chai D; Wang R; Bai N; Liang BB; Liu Y
J Antimicrob Chemother; 2011 May; 66(5):968-78. PubMed ID: 21393178
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Mathers Dunbar L; Hassman J; Tellier G
Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
[TBL] [Abstract][Full Text] [Related]
17. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Uthman MM; Uthman OA; Yahaya I
Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
[TBL] [Abstract][Full Text] [Related]
18. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
Roord JJ; Wolf BH; Gossens MM; Kimpen JL
Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis.
Howard KB; Blumenschein K; Rapp RP
Am J Health Syst Pharm; 1999 Aug; 56(15):1521-4. PubMed ID: 10478989
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults.
Sopena N; Martínez-Vázquez C; Rodríguez-Suárez JR; Segura F; Valencia A; Sabrià M
J Chemother; 2004 Feb; 16(1):102-3. PubMed ID: 15078008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
